Pfizer/Wyeth Will Produce (Incremental) Growth, Pfizer Assures Investors

Pfizer management, more bullish than the Street on long-term revenue forecasts for the combination of Pfizer and Wyeth, assured investors that incremental growth opportunities will emerge from the mega merger during a follow-up meeting with investors Jan. 27